SAM
EPZM

Shell Asset Management’s Epizyme, Inc EPZM Stock Holding History

Shell Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,836
Closed -$172K – 1508
2020
Q4 		$172K Hold
15,836
– – ﹤0.01% 1159
2020
Q3 		$189K Hold
15,836
– – ﹤0.01% 1057
2020
Q2 		$254K Sell
15,836
-138
-0.9% -$2.41K 0.01% 952
2020
Q1 		$248K Sell
15,974
-244
-2% -$5.24K 0.01% 939
2019
Q4 		$399K Sell
16,218
-415
-2% -$6.16K 0.01% 963
2019
Q3 		$172K Sell
16,633
-143
-0.9% -$1.8K ﹤0.01% 1149
2019
Q2 		$211K Sell
16,776
-384
-2% -$4.94K ﹤0.01% 1117
2019
Q1 		$213K Hold
17,160
– – ﹤0.01% 1100
2018
Q4 		$106K Sell
17,160
-1,500
-8% -$11.5K ﹤0.01% 1090
2018
Q3 		$198K Buy
+18,660
New +$213K ﹤0.01% 1101

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return